Cargando…
Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening
BACKGROUND: Breath volatile organic compounds (VOCs) have been reported as biomarkers of lung cancer, but it is not known if biomarkers identified in one group can identify disease in a separate independent cohort. Also, it is not known if combining breath biomarkers with chest CT has the potential...
Autores principales: | Phillips, Michael, Bauer, Thomas L., Cataneo, Renee N., Lebauer, Cassie, Mundada, Mayur, Pass, Harvey I., Ramakrishna, Naren, Rom, William N., Vallières, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689411/ https://www.ncbi.nlm.nih.gov/pubmed/26698306 http://dx.doi.org/10.1371/journal.pone.0142484 |
Ejemplares similares
-
Rapid Point-Of-Care Breath Test for Biomarkers of Breast Cancer and Abnormal Mammograms
por: Phillips, Michael, et al.
Publicado: (2014) -
Frequency and characterization of ancillary chest CT findings in COVID-19 pneumonia
por: Silva, Mario, et al.
Publicado: (2021) -
Pulmonary embolism in COVID-19: Ancillary findings on chest CT angiography
por: Scialpi, Michele, et al.
Publicado: (2021) -
Detection of an Extended Human Volatome with Comprehensive Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry
por: Phillips, Michael, et al.
Publicado: (2013) -
Ancillary Findings on CT Pulmonary Angiograms that are Negative for Pulmonary Embolism
por: Stein, Paul, et al.
Publicado: (2020)